why choose us

First received: January 18, 2023

Clinical Trial: Safety and Efficacy of the Therapy With BREINMAX® for the Treatment of Patients With Asthenia After COVID-19

Study Status: Completed

Recruit Status: Completed

Condition: Asthenia
COVID-19

Study Type: Interventional


Official Title: Prospective Multicentre Comparative Randomized Double Blind Placebo Controlled Study of Safety and Efficacy of the Therapy With BREINMAX® for the Treatment of Patients With Asthenia After Having the N

Brief Summary: This is prospective multicentre comparative randomized double blind placebo controlled study conducted in 6 medical facilities.The objective of the study is to assess the safety and efficacy of the sequential therapy with BREINMAX®, solution for intravenous infusion and intramuscular injection, and BREINMAX®, capsules for the treatment of patients with asthenia after having the novel coronavirus infection (COVID-19)

Read more